|
Current issue
Archive
Online First
About the journal
Editorial board
Editorial office
Publisher
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
6/2005
vol. 4 abstract:
How we can modify the risk of breast cancer?
Monika Zbucka
,
Monika Leśniewska
,
Paweł Knapp
,
Sławomir Wołczyński
Prz Menopauz 2005; 6: 70-75
Online publish date: 2005/12/28
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The multi-step process of carcinogenesis can be delayed, arrested or reversed by natural or synthetic agents. There are several independent risk factors for breast cancer development. Estimation of a women’s risk for breast cancer development is essential to identifying women who are most likely to benefit from chemoprevention. Treatment options for women who were at risk include increased surveillance, chemoprevention and prophylactic mastectomy.
In the National Surgical Adjuvant Breast and Bowel Project (NSABP) PI tamoxifen treatment 20 mg/day resulted in a 49% and 50% reduction of invasive and non-invasive breast cancer. Raloxifene is being evaluated in comparison with tamoxifen in the STAR study. The main outcome measure is breast cancer incidence and the results are expected in 2006. keywords:
breast cancer, chemoprevention, tamoxifen, raloxifene |
 |
